» Articles » PMID: 31947693

Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Jan 18
PMID 31947693
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive chronic disease characterized by excessing scarring of the lungs leading to irreversible decline in lung function. The aetiology and pathogenesis of the disease are still unclear, although lung fibroblast and epithelial cell activation, as well as the secretion of fibrotic and inflammatory mediators, have been strongly associated with the development and progression of IPF. Significantly, long non-coding RNAs (lncRNAs) are emerging as modulators of multiple biological processes, although their function and mechanism of action in IPF is poorly understood. LncRNAs have been shown to be important regulators of several diseases and their aberrant expression has been linked to the pathophysiology of fibrosis including IPF. This review will provide an overview of this emerging role of lncRNAs in the development of IPF.

Citing Articles

ANRIL upregulates TGFBR1 to promote idiopathic pulmonary fibrosis in TGF-β1-treated lung fibroblasts via sequestering let-7d-5p.

Wu W, Yu N, Chen W, Zhu Y Epigenetics. 2024; 19(1):2435682.

PMID: 39612365 PMC: 11610569. DOI: 10.1080/15592294.2024.2435682.


Interplay between Lung Diseases and Viral Infections: A Comprehensive Review.

Suri C, Pande B, Suhasini Sahithi L, Sahu T, Verma H Microorganisms. 2024; 12(10).

PMID: 39458339 PMC: 11510474. DOI: 10.3390/microorganisms12102030.


Development of a Lipid-encapsulated TGFβRI-siRNA Drug for Liver Fibrosis Induced by Schistosoma mansoni.

Chen Y, Lee Y, Lee C, Lin T, Hwu E, Cheng P PLoS Negl Trop Dis. 2024; 18(9):e0012502.

PMID: 39264964 PMC: 11421824. DOI: 10.1371/journal.pntd.0012502.


BRD4: an effective target for organ fibrosis.

Wei Q, Gan C, Sun M, Xie Y, Liu H, Xue T Biomark Res. 2024; 12(1):92.

PMID: 39215370 PMC: 11365212. DOI: 10.1186/s40364-024-00641-6.


Construction and Bioinformatics Analysis of ceRNA Regulatory Networks in Idiopathic Pulmonary Fibrosis.

Zhang M, Wu X, Zhu H, Fu C, Yang W, Jing X Biochem Genet. 2024; .

PMID: 38871957 DOI: 10.1007/s10528-024-10853-y.


References
1.
Cantin A, North S, Fells G, Hubbard R, Crystal R . Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest. 1987; 79(6):1665-73. PMC: 424497. DOI: 10.1172/JCI113005. View

2.
Raghu G, Collard H, Egan J, Martinez F, Behr J, Brown K . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183(6):788-824. PMC: 5450933. DOI: 10.1164/rccm.2009-040GL. View

3.
Wick G, Grundtman C, Mayerl C, Wimpissinger T, Feichtinger J, Zelger B . The immunology of fibrosis. Annu Rev Immunol. 2013; 31:107-35. DOI: 10.1146/annurev-immunol-032712-095937. View

4.
Geisler S, Coller J . RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol. 2013; 14(11):699-712. PMC: 4852478. DOI: 10.1038/nrm3679. View

5.
King Jr T, Schwarz M, Brown K, Tooze J, Colby T, Waldron Jr J . Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med. 2001; 164(6):1025-32. DOI: 10.1164/ajrccm.164.6.2001056. View